Bibliographic review on COVID 19 in patients with lung cancer
Keywords:
Key words, COVID-19, SARS-CoV-2, lung cancer, bibliographic reviewAbstract
COVID-19 is a pandemic disease produced by SARS-CoV-2 virus; the group of patients with lung cancer is vulnerable to this disease because of presenting an acquired immune depression due to administered oncospecific treatments, leading to higher exposition to complications if the patient gets this terrible disease striking worldwide nowadays. The objective of this review was exposing the risk and complications affronted by patients suffering lung cancer with oncospecific treatment if they get infected by SARS-CoV-2. The authors carried out a systematic review of the main articles published in Spanish and English by Cuban and foreign authors in high impact journals around the world, information reported by the World Health Organization, INFOMED and the Ministry of Public Health of Cuba. It was concluded that patients with lung cancer are not at a higher risk of catching COVID-19 than general population; it does exist certain evidence of that these patients could suffer a more serious infection if they get the disease.
Downloads
References
2. JAMA. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 February 24, 2020. Lancet [Internet]. March 9 [Citado 24/03/2020]; 2020.Disponible en : https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
3. Worldometer. COVID-19 Coronavirus Pandemic. Worldometer [Internet]. March 16[Citado 24/03/2020];2020.Disponible en: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?#countries
4. Zhang L, Zhu F, Xie L,et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Jul;31(7):894-901. Citado en PubMed; PMID: 32224151.
5. Colectivo de autores. Programa Integral para el Control del Cáncer en Cuba. Diagnóstico y tratamiento del cáncer de pulmón[Internet]. La Habana: Ciencias Médicas [Citado 24/03/2020]; 2020. http://www.ecimed.sld.cu/2020/01/28/programa-integral-para-el-control-del-cancer-en-cuba-diagnostico-y-tratamiento-del-cancer-de-pulmon/
6. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance[Internet].USA: World Health Organization[Citado 24/03/2020];2020. Disponible en: https://apps.who.int/iris/handle/10665/330893
7. WHO. Coronavirus disease. (COVID-19) Pandemic[Internet]. USA:World Health Organization[Citado 24/03/2020]; 2020.Disponible en : https://www.who.int/emergencies/diseases/novel-coronavirus-2019
8. Johns Hopkins Coronavirus Resource Center. Coronavirus COVID-19 global cases by the center for systems science and engineering [Internet]. [Citado 24/03/2020]; 2020. Disponible en: https://coronavirus.jhu.edu/map.html
9. World Health Organization .Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection, Interim guidance[Internet]. World Health Organization[Citado 24/03/2020]; 2020. Disponible en:https://apps.who.int/iris/bitstream/handle/10665/330374/WHO-2019-nCoV-laboratory-2020.1-eng.pdf
10. Al Shamsi HO, Alhazzani W, Alhuraiji A,et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. The Oncologist [Internet]. 2020 [Citado 24/03/2020];25:1-10. Disponible en: http://dx.doi.org/10.1634/theoncologist.2020-0213
11. Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020 Jul 28;71(15):762-768. Citado en PubMed;PMID: 32161940.
12. Chen N, Zhou M, Dong X,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513.Citado en PubMed;PMCID35076.
13. Páramo Fernández J. Coagulación, Dímero D y COVID-19.SETH [Internet] [Citado 24/03/2020]; 2020. Disponible en:https://www.seth.es/index.php/component/search/?searchword=Coagulaci%C3%B3n,%20D%C3%ADmero
14. Yang Y, Minghui Y, Chenguang S,et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. MedRxiv [Internet]. [Citado 24/03/2020]; 2020. Disponible en: https://www.medrxiv.org/content/10.1101/2020.02.11.20021493v2
15. Miyashita H, Mikami T, Chopra N,et al. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020 Aug;31(8):1088-1089. Citado en PubMed; PMID: 32330541.
16. Zhang L, Zhu F, Xie L,et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Jul;31(7):894-901. Citado en PubMed; PMID: 32224151.
17. Landman A, Feetham L, Stuckey D. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology [Internet]. [Citado 24/03/2020];2020. Disponible en : https://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(20)30096-6.pdf
18. American College of Surgeons. COVID-19: Guidance for triage of non-emergent surgical procedures. [Internet]. March 20[Citado 24/03/2020]; 2020.Disponible en: https://www.facs.org/covid-19/clinical-guidance/triage
19. National Health Service (NHS) England. Clinical guide for the management of non-coronavirus patients requiring acute treatment: Cancer (Publications approval reference: 001559). [Internet]. [Citado 24/03/2020];2020. Disponible en: https://www.nice.org.uk/Media/Default/About/COVID-19/Specialty-guides/cancer-and-COVID-19.pdf
20. Guckenberger M, Belka C, Bezjak A,et al. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):631-640.Citado en PubMed;PMID: 32589990.
21. Kirkby C, Mackenzie M. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Oncol. 2020 Jun;147:221. Epub 2020 Apr 6. PMID: 32342871; PMCID: PMC7194710.
22. American Society of Clinical Oncology: ASCO coronavirus resources. [Internet]; 2020. Disponible en: https://www.asco.org/asco-coronavirus-information
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
